Latest stories on APUS
Apimeds Pharmaceuticals to Implement Reverse Stock Split July 24
TipRanks25 · bearishgeneral
Apimeds Pharmaceuticals US, Inc. (APUS) files 8-K
SEC 8-K50 · neutralgeneral
APIMEDS PHARMACEUTIC (APUS) news roundup. 1 story in the past week, 3 over 30 days. Average 30-day sentiment is 43.7/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.